Recombinant Vector Vaccines

Recombinant vector vaccines are a type of vaccine which use a modified or "recombinant" virus or bacteria to deliver laboratory-made antigens to an organism, protecting it from disease. These vaccines are designed to be safer, more efficient and more effective than traditional vaccines, with fewer complications and a reduced rate of side effects. They can be used to protect against a wide range of infectious diseases, including influenza, and can be tailored to target different strains of a virus or bacteria. Recombinant vector vaccines are an important advancement in vaccine technology and have the potential to save millions of lives.

← Journal of Current Viruses and Treatment Methodologies

Related Articles

5 article(s) found

Potential Impact of Aedes Albopictus (Skuse,1894), an Arbovirus and Nematode Vector, on Human Public Health

Full-text HTML Download PDF Download XML

Biting Behaviour of The Filarial Vector Mosquito, Culex quinquefasciatusSay,in an Urban Area

Full-text HTML Download PDF Download XML

Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe

Full-text HTML Download PDF Download XML

FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

Full-text HTML Download PDF Download XML

Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized

Full-text HTML Download PDF Download XML